pelacarsen (AKCEA-APO(a)-LRx) - Novartis
Efficacy and Safety of Pelacarsen in Black/African American and Hispanic Participants With Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease: The Lp(a)FRONTIERS EXPANSION Study (AHA 2026) - Oct 8, 2026 - Pres time: Nov 9, 2026; 01:40 PM - 01:50 PM; Location: Heart Theater 2‚ Science and Technology Hall‚ South Hall‚ Heart Hub; In-Person; No abstract available 
Clinical • Late-breaking abstract • Atherosclerosis • Cardiovascular
https://eppro01.ativ.me/web/page.php?page=session&project=AHA26&id=P16188
 
Duccio Baldari; Hui Cao; Keith Ferdinand; Alexis Gutierrez; Kenny Onate Quiroz; Fatima Rodriguez; Michael Shapiro; james sullivan; Subha Venkataraman; Jing Wang; Wenyue Zhu
 
Oct 8, 2026
 
Prev Next